| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | EVP and Chief Medical Officer | Common Stock | 48.4K | $2.11M | $43.66 | May 2, 2024 | Direct |
| ABEONA THERAPEUTICS INC. | Director | Common Stock | 11K | $56.4K | $5.11 | Aug 13, 2024 | Direct |
| Ultragenyx Pharmaceutical Inc. | EVP and Chief Medical Officer | Stock Option (Right to Buy) | 2.35K | Mar 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ABEO | ABEONA THERAPEUTICS INC. | Aug 13, 2024 | 1 | $0 | 4 | Aug 14, 2024 | Director |
| ABEO | ABEONA THERAPEUTICS INC. | Aug 12, 2024 | 0 | $0 | 3 | Aug 14, 2024 | Director |
| RARE | Ultragenyx Pharmaceutical Inc. | May 2, 2024 | 1 | -$15.5K | 4 | May 3, 2024 | EVP and Chief Medical Officer |
| RARE | Ultragenyx Pharmaceutical Inc. | Apr 18, 2024 | 1 | -$6.26K | 4 | Apr 19, 2024 | EVP and Chief Medical Officer |
| RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2024 | 4 | -$66.6K | 4 | Mar 5, 2024 | EVP and Chief Medical Officer |
| RARE | Ultragenyx Pharmaceutical Inc. | Sep 27, 2023 | 1 | $0 | 4 | Sep 29, 2023 | EVP and Chief Medical Officer |
| RARE | Ultragenyx Pharmaceutical Inc. | May 1, 2023 | 2 | $0 | 4 | May 2, 2023 | EVP and Chief Medical Officer |
| RARE | Ultragenyx Pharmaceutical Inc. | May 1, 2023 | 0 | $0 | 3 | May 2, 2023 | EVP and Chief Medical Officer |